BRIEF-Merck KGaA, Darmstadt, Germany licenses four oncology research and development programs from Vertex
January 11, 2017 at 09:38 AM EST
* Merck KGaA, Darmstadt, Germany, licenses four oncology research and development programs from Vertex and becomes a leader in DNA damage and repair
